Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-98

haha.
I'm working on possibilities. IF there were any signs of being rejected, I would stay away.

I recalled many said CFDA would be receiving last November, but I did not think so as they just lodged at that time.

CFDA merged into a new department SAMR, this caused about 2-3 months delays.
I think formal SAMR/CFDA approval is not far away especially ASX announcement confirmed WHA infant formula passed SAMR/CFDA's technical evaluation.